Clinical trial
Scandinavian Candesartan Acute Stroke Trial (SCAST)
NCT00120003 · Ullevaal University Hospital, Other · Completed
Key facts
| NCT number | NCT00120003 |
|---|---|
| Title | Scandinavian Candesartan Acute Stroke Trial (SCAST) |
| Official title | Scandinavian Candesartan Acute Stroke Trial |
| Lead sponsor | Ullevaal University Hospital, Other |
| Collaborators | Southern-Eastern Norway Health Authorities RHF AstraZeneca Industry Takeda |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug |
| Interventions | Candesartan Cilexetil, Placebo |
| Enrollment | 2,500 |
| Start date | Jun 1, 2005 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Jul 14, 2005 |
| Last update posted | Jul 1, 2011 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: